Liposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis

References

• Agarwal R, Katare OP, Vyas SP. (2011). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43–52
   Web of Science ®Google Scholar
• Agarwal R, Saraswat A, Kaur I, et al. (2002). A novel liposomal formulation of dithranol for psoriasis: preliminary results. J Dermatol 29:529–32
   PubMed Web of Science ®Google Scholar
• Aisha AFA, Majid AMSA, Ismail Z. (2014). Preparation and characterization of nano liposomes of Orthosiphon stamineus ethanolic extract in soybean phospholipids. BMC Biotechnol 14:23
   PubMed Web of Science ®Google Scholar
• Basu S, Shivhare US, Raghavan GSV. (2007). Time dependent rheological characteristics of pineapple jam. Int J Food Eng 3:1–10
   Web of Science ®Google Scholar
• Bendtzen K, Diamant M, Faber V. (1990). Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine 2:423–9
   PubMedGoogle Scholar
• Bhatia A, Raza K, Singh B, Katare OP. (2009). Phospholipid-based formulation with improved attributes of coal tar. J Cosmet Dermatol 8:282–8
   PubMed Web of Science ®Google Scholar
• Bhatia A, Singh B, Raza K, et al. (2012). Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis. J Drug Target 20:544–50
   PubMed Web of Science ®Google Scholar
• Bhatia A, Singh B, Wadhwa S, et al. (2014). Novel phospholipid-based topical formulations of tamoxifen: evaluation for antipsoriatic activity using mouse-tail model. Pharm Dev Technol 19:160–3
   PubMed Web of Science ®Google Scholar
• Bladon PT, Taylor M, Wood EJ, Cunliffe WJ. (1985). Effect of crude coal tar in the mouse-tail model of psoriasis. Arch Dermatol Res 277:121–5
   PubMed Web of Science ®Google Scholar
• Bosman B, Matthiesen T, Hess V, Friderichs E. (1992). A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test. Skin Pharmacol 5:41–8
   PubMedGoogle Scholar
• Chhibber T, Wadhwa S, Chadha P, et al. (2015). Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. J Drug Target 23:943–52
   PubMed Web of Science ®Google Scholar
• Christiansen K. (1999). Fusidic acid non-antibacterial activity. Int J Antimicrob Agent 12:S73–8
   Google Scholar
• Cortesi R, Romagnoli R, Menegatti E, et al. (2004). Liposomes containing distamycins: preparation, characterization and antiproliferative activity. Drug Del 11:83–8
   PubMed Web of Science ®Google Scholar
• Dhanabal SP, Dwarampudi LP, Muruganantham N, Vadivelan R. (2012). Evaluation of the antipsoriatic activity of aloe vera leaf extract using a mouse tail model of psoriasis. Phytother Res 26:617–19
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. (2009). Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies. Colloids Surf B Biointerfaces 70:198–206
   PubMed Web of Science ®Google Scholar
• Drulis-Kawa Z, Dorotkiewicz-Jach A. (2010). Liposomes as delivery systems for antibiotics. Int J Pharm 387:187–98
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia. (2008). European Directorate for the quality of medicines. 6th ed. Strasbourg, France: Council of Europe, 1645
   Google Scholar
• Falck E, Hautala JT, Karttunen MP, et al. (2006). Interaction of fusidic acid with lipid membranes: implications to the mechanism of antibiotic activity. Biophys J 91:1787–99
   PubMed Web of Science ®Google Scholar
• Fisher A. (1996). Lasers and allergic contact dermatitis to topical antibiotics, with particular reference to bacitracin. Cutis Oct 58:252–4
   PubMed Web of Science ®Google Scholar
• Forstrom L, Lassus A. (1972). Fucidic acid and psoriasis. Ann Clin Res 6:165–6
   Google Scholar
• Fuller FW. (2009). The side effects of silver sulfadiazine. J Burn Care Res 30:464–70
   PubMed Web of Science ®Google Scholar
• Gabrijelcic V, Sentjurc M. (1995). Influence of hydrogels on liposome stability and on the transport of liposome entrapped substance into the skin. Int J Pharm 118:207–12
   Web of Science ®Google Scholar
• Godtfredsen WO, Jahnsen S, Lorck H, et al. (1962). Fusidic acid: a new antibiotic. Nature 193:987–8
   PubMed Web of Science ®Google Scholar
• Hall-Smith P. (1971). Fusidic acid treatment in psoriasis. Lancet 2:544
   PubMed Web of Science ®Google Scholar
• Hallaj-Nezhadi S, Hassan M. (2015). Nanoliposome-based antibacterial drug delivery. Drug Del 22:581–89
   PubMed Web of Science ®Google Scholar
• Hofbauer M, Dowd PM, Atkinson J, et al. (1988). Evaluation of a therapeutic concentration of dithranol in the mouse-tail test. Br J Dermatol 118:85–9
   PubMed Web of Science ®Google Scholar
• Jackson N. (1971). Fusidic acid treatment in psoriasis. Lancet 2:712
   PubMed Web of Science ®Google Scholar
• Katare OP, Raza K, Singh B, Dogra S. (2010). Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Ind J Dermatol Venereol Leprol 76:612–21
   PubMed Web of Science ®Google Scholar
• Kurwa A, Abdel-Aziz AH. (1973). Preliminary clinical trial of fusidic acid in psoriasis. Br J Clin Pract 27:92–4
   PubMedGoogle Scholar
• Levantine AV. (1971). Fusidic acid treatment in psoriasis. Lancet 2:661
   PubMed Web of Science ®Google Scholar
• Levy SB, Marshall B. (2004). Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10:S122–9
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Hoey C. (2009). Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 49:1541–9
   PubMed Web of Science ®Google Scholar
• Lowes MA, Bowcock AM, Krueger JG. (2007). Pathogenesis and therapy of psoriasis. Nature 445:866–73
   PubMed Web of Science ®Google Scholar
• Mackey JP. (1974). Fusidic acid in psoriasis (letter). Lancet 2:232–7
   PubMed Web of Science ®Google Scholar
• Mahajan R, Handa S. (2013). Pathophysiology of psoriasis. Ind J Dermatol Venereol Leprol 79:1–9
   PubMedGoogle Scholar
• Marples RR, Heatom CL, Kligman AM. (1973). Staphylococcus aureus in psoriasis. Arch Dermatol 107:568–70
   PubMed Web of Science ®Google Scholar
• Mason AR, Mason J, Cork M, et al. (2013). Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 3:CD005028
   PubMed Web of Science ®Google Scholar
• Menter A, Korman NJ, Elmets CA, et al. (2009). Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60:643–59
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulasekharam V. (1980). Liposomes-a selective drug delivery system for the topical route of administration. I. Lotion dosage form. Life Sci 26:1473–7
   PubMed Web of Science ®Google Scholar
• Mitchell DJ, Winham BW. (1981). Micelles, vesicles and microemulsions. J Chem Soc Faraday Trans II 77:601–29
   Web of Science ®Google Scholar
• Nicolosia D, Cuprib S, Genovesea C, et al. (2015). Nanotechnology approaches for antibacterial drug delivery: preparation and microbiological evaluation of fusogenic liposomes carrying fusidic acid. Int J Antimicrob Agents 45:622–6
   PubMed Web of Science ®Google Scholar
• Nyfors A. (1973). Fucidin in psoriasis. A double-blind study of twenty psoriatics over two periods of four weeks each. Dermatologica 46:281–4
   Google Scholar
• Owen CM, Chalmers RJG, Osullivan T, Griffiths CE. (2001). A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 145:886–90
   PubMed Web of Science ®Google Scholar
• Rahman M, Akhter S, Ahmad J, et al. (2015). Nanomedicine based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Expert Opin Drug Deliv 12:635–52
   PubMed Web of Science ®Google Scholar
• Raza K, Katare OP, Setia A, et al. (2011a). Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul 30:225–36
   Web of Science ®Google Scholar
• Raza K, Singh B, Lohan S, et al. (2013a). Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm 456:65–72
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Mahajan A, et al. (2011b). Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target 19:293–330
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singal P, et al. (2013b). Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B: Biointerfaces 105:67–74
   PubMed Web of Science ®Google Scholar
• Ruozi B, Belletti D, Tombesi A, et al. (2011). AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study. Int J Nanomed 6:557–63
   PubMed Web of Science ®Google Scholar
• Saraswat A, Agarwal R, Katare OP, et al. (2007). A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis. J Dermatol Treat 18:40–5
   PubMed Web of Science ®Google Scholar
• Sebok B, Bonnekon B, Kerenyi M, Gollnick H. (2000). Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis. Skin Pharmacol Appl Skin Physiol 13:285–91
   PubMedGoogle Scholar
• Skov R, Frimodt-Moller N, Espersen F. (2001). Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagnos Microb Infect Dis 20:111–16
   Web of Science ®Google Scholar
• Touitou E. (2002). Drug delivery across the skin. Expert Opin Biol Ther 2:723–33
   PubMed Web of Science ®Google Scholar
• Turnidge J. (1999). Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 12:S23–34
   PubMed Web of Science ®Google Scholar
• US Pharmacopoeial Convention, USP 32-NF 27. (2009). Pharmaceutical stability, 2009;1150:662–3
   Google Scholar
• Valenta C, Wanka M, Heidlas J. (2000). Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J Control Release 63:165–73
   PubMed Web of Science ®Google Scholar
• Vanangamudi SS, Srinivasan M, Chulliel NN, et al. Novel dermaceutical cream made using sodium fusidate. Pub. no. US 2011/0257144 A1
   Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141–51
   PubMed Web of Science ®Google Scholar
• Voetmann E. (1971). Fusidic acid treatment in psoriasis. Lancet 2:435
   PubMed Web of Science ®Google Scholar
• Vogel GH, Vogel WH. (2002). Drug discovery and evaluation: pharmacological assays. 2nd ed. Germany: Springer-Verlag, 1325
   Google Scholar